In Brief: Heartport
This article was originally published in The Gray Sheet
Executive Summary
Heartport: Acquires Utah Biomedical Test Laboratory, which the Redwood City, California company plans to use as the principal U.S. training center for its Port-Access minimally invasive cardiac surgery. Training is scheduled to begin this quarter at the 50,000-square-foot surgical laboratory. The facility will enable Heartport to "centralize and accelerate its U.S. training activities" and to "substantially accelerate and broaden its research and development activities," the firm says. On Oct. 7, Heartport received FDA clearance for the EndoCPB catheter system to perform Port-Access coronary artery bypass grafting and other cardiac surgeries. Heartport plans to launch the system by mid-1997 following physician training ("The Gray Sheet" Oct. 14, I&W-1)...